Purchase Order HHSN272201400119P
Award Date 12/2/13
Potential Completion Date 12/2/13
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Columbia, MD 21045, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract award is for $16,490 to A&G Pharmaceutical, Inc. (doing business as A & G Pharmaceutical Inc. and Precision Antibody) by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the U.S. Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) call with a firm-fixed price pricing type. A&G Pharmaceutical is a for-profit manufacturer of goods specializing in custom antibody development services and...
- The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...
- This is a $23,086.75 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc., doing business as Precision Antibody. Precision Antibody is a for-profit manufacturer of goods that provides custom antibody development services to support biomedical research. This contract is not set aside for small businesses. The award supports research efforts through the...
- This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...
- This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The contract is for the preparation of monoclonal antibodies against the MARCH1 protein, with a ceiling value of $16,900.00 and a performance period through July 31, 2025. A&G Pharmaceutical is a for-profit manufacturer of biological...
- This is a federal contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The $199,380 firm-fixed-price contract is for research and development related to biomedical products and was awarded on September 14, 2012, with a completion date of September 13, 2013. The contract does not have a set-aside designation. A&G Pharmaceutical, Inc. is a...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...
- This federal contract was awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for a COVID-19-related project analyzing a novel truncated form of the ACE2 receptor. The $19,349.65 firm-fixed-price purchase order was awarded on June 18, 2020, with a period of performance through June 19, 2020. The contract was awarded without any set-aside designation, indicating open competition....
- This federal contract award, identified by the ID HHSF223201011747P, was issued by the Food and Drug Administration (FDA) to A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $8,245 firm-fixed-price purchase order is for precision antibody services, including custom monoclonal and polyclonal antibody development, cell line generation, and specialized laboratory testing. The contract is part of a larger $100 million Blanket Purchase Agreement (BPA) awarded by the National...
- This is a firm-fixed price delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, to A&G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $107,461.88 contract is for the delivery of polyclonal rat antibodies and monoclonal rat antibodies against glycol-chitosan nanoparticles. This award is part of a larger $100 million single-award...